Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: A randomized, double-blind, placebo-controlled, clinical trial

Human Reproduction

Volumn 13, Issue 3, 1998, Pages 596-603

  Kamischke, A ^a   Behre, H M ^a   Bergmann, M ^b   Simoni, M ^a   Schafer T ^b   Nieschlag, E ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Electron microscopy; Male idiopathic infertility; Randomized controlled clinical trial; Recombinant human FSH; Semen parameters

Indexed keywords

DNA; FOLLITROPIN; INHIBIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTRON MICROSCOPY; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; SEMEN ANALYSIS; SPERM; SPERMATOZOON MOTILITY; TESTIS SIZE;

EID: 0031894748     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.3.596     Document Type: Article

References (45)

1. Acosta, A.A., Khalifa, E. and Oehninger, S. (1992) Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Hum. Reprod., 7, 1067-1072.
2. Bacetti, B., Bernieri, G., Burrini, A.G. et al. (1995) Notulae seminologicae. 5. Mathematical evaluation of interdependent submicroscopic sperm alterations. J. Androl., 16, 356-371.
3. Baker, G., Brindsen, P., Jouannet, P. et al. (1992) Treatment of severe male infertility with pure follicle stimulating hormone (FSH): the need for a properly controlled multicentre trial. Hum. Reprod., 8, 500-501.
4. Ballesca, J.L., Barri, P., Calderon, G. et al. (1995) Treatment of male factor with urofollitropin after the failure of a first attempt of in vitro fertilization (IVF). J. Assist. Reprod. Genet., 12, 167S.
5. Bals-Pratsch, M., Knuth, U.A., Hönigl, W. et al. (1989) Pulsatile GnRH-therapy in oligozoospermic men does not improve seminal parameters despite decreased FSH levels. Clin. Endocrinol., 30, 549-560.
6. Bartoov, B., Eltes, F. and Lunenfeld, E. (1994) Sperm quality of subfertile males before and after treatment with follicle-stimulating hormone. Fertil. Steril., 61, 727-734.
7. Behre, H.M., Hacker-Klom, U., Göhde, W. and Nieschlag, E. (1989) Objective and accurate measurement of sperm concentration by flow cytometry. In Serio, M. (ed.), Ares-Serono Symposia Review, Supplement I, Miniposters, IV International Congress of Andrology, Florence, Italy.
8. Behre, H.M., Nashan, D. and Nieschlag, E. (1990) Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int. J. Androl., 12, 395-403.
9. Behre, H.M., Kliesch, S., Schädel, F. and Nieschlag, E. (1995) Clinical relevance of scrotal and transrectal ultrasonography in andrological patients. Int. J. Androl., 18, 27-31.
10. Ben Rafael, Z., Ashkenazi, J., Farhi, J. et al. (1995) Pure FSH (pFSH) treatment to male partners in IVF cycles due to idiopathic oligo-teratoasthenozoospermia (OTA) syndrome. J. Assist. Reprod. Genet., 12, 52S.
11. Comodo, F., Vargiu, N., Farina, M. et al. (1996) Double-blind FSH-HP/ placebo treatment of severe male factor related infertility: effect on sperm parameters and IVF/ICSI outcome. ASHRE Poster S41.
12. Cooper, T.G., Neuwinger, J., Bahrs, S. and Nieschlag, E. (1992) Internal quality control of semen analysis. Fertil. Steril., 58, 172-178.
13. Glander, H.-J. and Kratzsch, J. (1997) Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotropin-releasing hormone (GnRH). Andrologia, 29, 23-28.
14. Gromoll, J., Simoni, M. and Nieschlag, E. (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab., 81, 1367-1370.
15. Heseltine, D., White, M.C. Kendall-Taylor, P. et al. (1989) Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone. Clin. Endocrinol., 31, 411-423.
16. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (1996) Good Clinical Practice: Consolidated Guideline. Geneva, E6GCPD12, pp. 1-71.
17. Jockenhövel, F., Fingscheidt, U., Khan, S.A. et al. (1990) Bio and immunoactivity of FSH in serum after intramuscular injection of highly purified urinary human FSH in normal men. Clin. Endocrinol., 33, 573-584.
18. Keck, C., Behre, H.M., Jockenhövel, F. and Nieschlag, E. (1994) Ineffectiveness of kallikrein in treatment of idiopathic male infertility: a double-blind, randomized, placebo-controlled trial. Hum. Reprod., 9, 325-329.
19. Kliesch, S., Behre, H.M. and Nieschlag, E. (1994) High efficacy of gonadotropin or pulsatile GnRH treatment in hypogonadotropic hypogonadal men. Eur. J. Endocrinol., 131, 347-354.
20. Kliesch, S., Behre, H.M. and Nieschlag, E. (1995) Recombinant human follicle stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadal male. Fertil. Steril., 62, 1326-1328.
21. Knuth, U.A., Hönigl, W., Bals-Pratsch, M. et al. (1987) Treatment of severe oligozoospermia with HCG/HMG. A placebo-controlled double blind trial. J. Clin. Endocrinol. Metab., 65, 1081-1087.
22. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1994) Clinical pharmacology of recombinant human follicle stimulating hormone. II Single doses and steady state pharmacokinetics. Fertil. Steril., 61, 679-686.
23. Leifke, E. and Nieschlag, E. (1996) Male infertility in the light of evidence-based medicine. Andrologia, 28, 23-30.
24. Mannaerts, B., de Leeuw, R., Geelen, J. et al. (1991) Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology, 129, 2623-2630.
25. Matorras, R., Perez, C., Corcostegui, B. et al. (1997) Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum. Reprod., 12, 24-28.
26. Merino, G., Carranza-Lira, S., Martinez-Chequer, J.C. et al. (1996) Sperm characteristics and hormonal profile before and after treatment with follicle-stimulating hormone in infertile patients. Arch. Androl., 37, 197-200.
27. Montag, M., Zeitler, S., Stuckensen, J. and Wiedemann, R. (1995) FSH-Therapie bei idiopathischer Infertilität. 7. Jahrestagung der Deutschen Gesellschaft für Andrologie p. 2.5
28. Neugebauer, D.C., Neuwinger, J., Jockenhövel, F. and Nieschlag, E. (1990) '9 + 0 axoneme in spermatozoa and some nasal cilia of a patient with totally immotile spermatozoa associated with thickened sheath and short midpiece. Hum. Reprod., 5, 981-986.
29. Neuwinger, J., Behre, H.M. and Nieschlag, E. (1990) External quality control in the andrology laboratory: an experimental multicenter trial. Fertil. Steril., 54, 308-314.
30. Nieschlag, E. and Leifke, E. (1997) Empirical therapies for idiopathic infertility. In Nieschlag, E. and Behre, H.M. (eds), Andrology: Male Reproductive Health and Dysfunction. Springer, Heidelberg, pp. 313-319.
31. Organization for Economic Co-operation and Development (OECD) (1992) The OECD Principles of Good Laboratory Practice. OECD, Paris, Environment monograph No. 45.
32. Ranieri, M., Sturdy, J., Marchant, S. et al. (1994). Follicle-stimulating hormone (pFSH) treatment for male factor infertility with previous failed fertilization in vitro. Hum. Reprod., 3, 19.
33. Rolf, C., Behre, H.M. and Nieschlag, E. (1996) Tamoxifen bei männlicher Infertilität: Analyse einer fragwürdigen Therapie. Dtsch. Med. Wsch., 121, 33-39.
34. Sigg, C. and Baciu, M. (1994) Improvement of sperm concentration and bovine mucus penetration in idiopathic oligozoospermia by administration of pure FSH. Hum. Reprod., 9 (suppl. 4), 47.
35. Simoni M. and Nieschlag E. (1995) FSH in therapy: physiological basis, new preparations and clinical use. Reprod. Med. Rev., 4, 163-177.
36. Strehler, E., Sterzik, K., De Santo, M. et al. (1997) The effect of follicle-stimulating hormone therapy on sperm quality: an ultrastructural mathematical evaluation. Androl. 18, 439-447.
37. van Alphen, M.M.A., van de Kant, H.J.G. and de Rooij, D.G. (1988) Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey. Endocrinology, 123, 1449-1455.
38. Vandekerckhove, P., Lilford, R. and Hughes, E. (1995) Kinin enhancing drugs for male infertility. In Lilford R., Hughes, E. and Vandekerckhove, P. (eds), Subfertility Module of the Cochrane Database of Systematic Reviews. Cochrane Library. The Cochrane Collaboration, Issue 2, updated July 1995. Update Software, Oxford.
39. Vandekerckhove, P., Lilford, R. and Hughes, E. 1996) The medical treatment of idiopathic oligo/asthenospermia: androgens (mesterolone or testosterone) versus placebo or no treatment. In Lilford R., Hughes, E. and Vandekerckhove, P. (eds), Subfertility Module of the Cochrane Database of Systematic Reviews. Cochrane Library. The Cochrane Collaboration, Issue 2, updated March 1996, Update Software, Oxford.
40. Weinbauer, G.F., Behre, H.M. and Nieschlag, E. (1992) Human FSH transiently stimulates size and spermatogenesis in the adult intact non-human primate. Acta Endocrinol., 126, 97.
41. Weinbauer, G.F., Gromoll, J., Simoni, M. and Nieschlag, E. (1997) Physiology of testicular function. In Nieschlag E. and Behre H.M. (eds), Andrology: Male Reproductive Health and Dysfunction, Springer, Heidelberg, pp. 25-54.
42. World Health Organization (1992a) WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edn. Cambridge University Press, Cambridge.
43. World Health Organization (WHO) Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on the Prevention and Management of Infertility (1992b) A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int. J. Androl., 15, 299-307.
44. World Health Organization (1993a) Internal Quality Control for Assays of Reproductive Hormones: Guidelines for Laboratories. World Health Organization, Geneva.
45. World Health Organization (1993b) Guidelines For Good Clinical Practice (GCP) for Trials on Pharmaceutical Products. World Health Organization, Geneva.